p73 G4C14 to A4T14 polymorphism is associated with colorectal cancer risk and survival

Table 4 The relationship between p73 protein expression and clinicopathological characteristics in 383 colorectal cancer patients n (%)

Clinicopathological characteristics	No. of cases	p73 protein expression		P
		Positive	Negative
		(n = 252)	(n = 131)
Age (yr)				0.45
< 60	166	113 (68.1)	53 (31.9)
≥ 60	217	139 (64.1)	78 (35.9)
Gender				1.00
Male	203	134 (66.0)	69 (34.0)
Female	180	118 (65.6)	62 (34.4)
Histological type				0.19
Well	256	169 (66.0)	87 (34.0)
Moderate	102	64 (62.7)	38 (37.3)
Poorly	12	7 (58.3)	5 (41.7)
Mucinous	13	12 (92.3)	1 (7.7)
Invasion depth				0.003
Mucosa	3	1 (33.3)	2 (66.7)
Submucosa	9	9 (100)	0 (0)
Muscle	47	39 (83.0)	8 (17.0)
Subserosa	324	203 (62.7)	121 (37.3)
Lymph node metastasis				0.67
Positive	175	113 (64.6)	62 (35.4)
Negative	208	139 (66.8)	69 (33.2)
Dukes’ stage				0.06
A	3	1 (33.3)	2 (66.7)
B1	43	36 (83.7)	7 (16.3)
B2	162	102 (63.0)	60 (37.0)
C1	13	10 (76.9)	3 (23.1)
C2	148	92 (62.2)	56 (37.8)
D	14	11 (78.6)	3 (21.4)